PYRIMIIDINVERBINDUNGEN
European patent · EP1597251 · Deleted
Register entry
- Publication number
- EP1597251
- Application number
- EP04710264
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Feb 11, 2004
- Published
- Nov 23, 2005
- Granted
- Jun 10, 2009
- Deleted
- Feb 28, 2010
- Reason
- Annual fee unpaid
- IPC classes
- C07D 403/12 (2006.01)C07D 239/48 (2006.01)C07D 405/12 (2006.01)A61K 31/505 (2006.01)A61K 31/506 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 448795 P 20.02.2003
- PCT application
- PCT/US2004/004197 11.02.2004
- PCT publication
- WO2004/074244 02.09.2004
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 22, 2010
Deleted, fee unpaid
Published in Swissreg on 22.09.2010
- Jun 10, 2009
Granted
Published in Swissreg on 10.06.2009
Parties
Inventor
DAVIS-WARD, Ronda, GlaxoSmithKline
Research Triangle Park, NC 27709, US
MOOK, Robert Anthony Jr., GlaxoSmithKline
Research Triangle Park, NC 27709, US
NEEB, Michael J., GlaxoSmithKline
King of Prussia, PA, US
SALOVICH, James M., GlaxoSmithKline
Research Triangle Park, NC 27709, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.